CL2009000304A1 -
Compounds derived from condensed heterocycles, pharmaceutical composition of compounds derived from pyrazolo [1,5-a] pyrimidine and [1,2,4] triazolo11,5-a] pyrimidine; and its use to treat hepatitis c.
- Google Patents
Compounds derived from condensed heterocycles, pharmaceutical composition of compounds derived from pyrazolo [1,5-a] pyrimidine and [1,2,4] triazolo11,5-a] pyrimidine; and its use to treat hepatitis c.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
Abstract
Compuestos derivados de heterociclos condensados, composición farmacéutica, y su uso para tratar hepatitis C.Compounds derived from condensed heterocycles, pharmaceutical composition, and their use to treat hepatitis C.
CL2009000304A2008-03-312009-02-10
Compounds derived from condensed heterocycles, pharmaceutical composition of compounds derived from pyrazolo [1,5-a] pyrimidine and [1,2,4] triazolo11,5-a] pyrimidine; and its use to treat hepatitis c.
CL2009000304A1
(en)
Compounds derived from condensed heterocycles, pharmaceutical composition of compounds derived from pyrazolo [1,5-a] pyrimidine and [1,2,4] triazolo11,5-a] pyrimidine; and its use to treat hepatitis c.
Compounds derived from imidazo [1,2-a] pyrazine; pharmaceutical composition; and use of the compounds as protein kinase inhibitors in the treatment of cancer.
Substituted heterocyclic compounds derived from imidazo [4,5-d] pyridazine, imidazo [4,5-c] pyridazine, imidazo [4,5d] pyrimidine, among others; pharmaceutical composition comprising said compounds; and use to treat the hepatitis c virus.
Compounds derived from 5-phenyl-1h-pyridin-2-one and 5-phenyl-pyrazin-2-one, bruton tyrosine kinase inhibitors (btk); process of preparation of the compounds, intermediate compound, pharmaceutical composition and use in the treatment of inflammatory and / or autoimmune diseases.
Compounds derived from pyrrolo [2,3-b] pyrazines; and its use in autoimmune disease, inflammatory disorders, proliferative disorders, cancer, mediated by selective inhibitors of jak 3.
Compounds derived from pyrrolo [2,3 b] pyrazine, inhibitors jak and cyk; and its uses in the treatment of inflammatory diseases, autoimmune and cancer.
Compounds derived from quinazoline or pyrido [2,3-d] pyrimidine, autophagy inhibitors; pharmaceutical composition; and its use for the treatment of cancer, pancreatitis, neurodegeneration, among others.
Substituted triazine-derived compounds, mediated by inhibition of p13 and mtor kinase; pharmaceutical composition; preparation procedure; and its use in the treatment of different types of cancer.
Compounds derived from pyrrolo [2,3-d] pyrimidine, inhibitors of janus kinase (jak1); pharmaceutical composition; and use for the treatment of an autoimmune disease, cancer, myeloproliferative disorder, an inflammatory disease, or organ transplant rejection.
Compounds derived from pyrimido [5,4-d] pyrimidine, which act as tyrosine kinase inhibitors; and pharmaceutical compositions that comprise them, useful in the treatment of diseases characterized by excessive or abnormal cell proliferation
Compounds derived from imidazo [1,2-a] pyridine; preparation procedure; pharmaceutical composition; intermediate compounds; and use in the treatment of cancer.
Compounds derived from triazolo [4,3-a] pyridine; preparation procedure; pharmaceutical composition; and use in the treatment of diseases such as cancer.
DERIVATIVES OF 1,2,3,4-TETRAHYDROPIRROLO [1,2] PIRAZINA-6-CARBOXAMIDS AND 2,3,4,5-TETRAHYDROPIRROL [1,2] [1,4] -DIAZEPINA -7-CARBOXAMIDS THEIR PREPARATION AND ITS APPLICATION IN THERAPEUTICS
Compounds derived from condensed heterocycles, pharmaceutical composition of compounds derived from pyrazolo [1,5-a] pyrimidine and [1,2,4] triazolo11,5-a] pyrimidine; and its use to treat hepatitis c.